Houjie Liang

机构：Army Medical University, Southwest Hospital

发表论文 12 篇 · 总被引 1292 次 · h-index 9

代表论文

• Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial (2023 · The Lancet · 被引 1104)
• Non-alcoholic fatty liver disease promotes liver metastasis of colorectal cancer via fatty acid synthase dependent EGFR palmitoylation (2024 · Cell Death Discovery · 被引 37)
• Efficacy, Safety, and Immunogenicity of HLX04Versus Reference Bevacizumab in Combination with XELOX or mFOLFOX6 as First-Line Treatmentfor Metastatic Colorectal Cancer: Results of a Randomized, Double-Blind Phase IIIStudy (2021 · BioDrugs · 被引 29)
• Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancer (2022 · Journal of the National Cancer Center · 被引 28)
• HILPDA-mediated lipidomic remodelling promotes radiotherapy resistance in nasopharyngeal carcinoma by accelerating mitophagy (2023 · Cellular and Molecular Life Sciences · 被引 26)
• Hyperglycemia induces an immunosuppressive microenvironment in colorectal cancer liver metastases by recruiting peripheral blood monocytes through the CCL3-CCR1 axis (2025 · Journal for ImmunoTherapy of Cancer · 被引 15)